Benzinga  Sep 3  Comment 
Analysts at Citi initiated coverage on Ultragenyx Pharmaceutical Inc (NASDAQ: RARE) with a Sell rating. Ultragenyx Pharmaceutical shares closed at $121.69 yesterday. Analysts at Keefe, Bruyette & Woods initiated coverage of Capitala Finance...
FiercePharma  Aug 26  Comment 
Medivation made a name for itself with Xtandi, the prostate cancer med that's now giving Johnson & Johnson's Zytiga a run for its money. Now, it wants to challenge other drugmakers in the PARP inhibitor field, too. 
Benzinga  Aug 24  Comment 
Medivation, Inc. (NASDAQ: MDVN) and BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) announced today that they have entered into an asset purchase agreement under which Medivation will acquire all worldwide rights to talazoparib (formerly referred to...
Motley Fool  Jul 31  Comment 
Medivation's Xtandi sales continued to climb in the second quarter.
TheStreet.com  Jul 13  Comment 
NEW YORK (TheStreet) -- Shares of Medivation are down 0.77% to $105.99 on Monday after JMP Securities lowered its 2015 earnings estimates to $2.59 per share from $2.62, with 2016 earnings cut to $4.17 from $5.29 per share. Medivation is a...
Motley Fool  Jul 11  Comment 
The reason behind Medivation Inc.'s June share price tumble
Benzinga  Jun 17  Comment 
Medivation (NASDAQ: MDVN) and Astellas announced today that the first patients have been enrolled in TRUMPET (Treatment Registry for Outcomes in CRPC Patients), a prospective observational patient registry designed to better understand the unique...



Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki